
Lixiana: Uses, Side Effects, Benefits/Risks | Drugs.com
Lixiana is an anticoagulant medicine (a medicine that prevents blood clotting) used in adults: to prevent stroke (caused by blood clots in the brain) and systemic embolism (blood clots in other …
Edoxaban - Wikipedia
Edoxaban, sold under the brand name Lixiana among others, is an anticoagulant medication and a direct factor Xa inhibitor. [3] It is taken by mouth. [3] Compared with warfarin it has fewer …
Lixiana - Uses, Side Effects, Interactions - MedBroadcast.com
Lixiana: Edoxaban belongs to the family of medications called anticoagulants. Anticoagulants prevent harmful blood clots from forming in the blood vessels by reducing the ability of the …
Edoxaban Uses, Side Effects & Warnings - Drugs.com
Edoxaban is used to lower the risk of stroke caused by a blood clot in people with a heart rhythm disorder called atrial fibrillation. edoxaban is used when the atrial fibrillation is not caused by a …
LIXIANA® (edoxaban) | Official Site for Healthcare Professionals
Official site of LIXIANA® (edoxaban), a once-daily, oral direct factor Xa inhibitor for patients with nonvalvular atrial fibrillation (nonvalvular afib) or venous thromboembolism (VTE)
Edoxaban (oral route) - Mayo Clinic
2025年2月1日 · Edoxaban is used to prevent stroke and blood clots in patients with a certain heart rhythm problem (eg, nonvalvular atrial fibrillation). Edoxaban is also used to treat deep …
Lixiana - European Medicines Agency (EMA)
Lixiana is an anticoagulant medicine (a medicine that prevents blood clotting) used in adults: to prevent stroke (caused by blood clots in the brain) and systemic embolism (blood clots in other …
Edoxaban: a medicine to help prevent blood clots - NHS
Brand name: Lixiana. Find out how edoxaban helps to prevent blood clots and reduces risk of heart attacks and stroke, and how to take it. NHS medicines information on edoxaban – what …
Edoxaban (Savaysa/Lixiana) to Prevent Strokes - StopAfib.org
2021年7月4日 · Edoxaban (Savaysa ® /Lixiana ®) is an anticoagulant medication. It is approved for stroke prevention in people with atrial fibrillation. 1 Edoxaban was approved by the US …
SUMMARY OF PRODUCT CHARACTERISTICS - LIXIANA
Lixiana is indicated in prevention of stroke and systemic embolism in adult patients with nonvalvular atrial fibrillation (NVAF) with one or more risk factors, such as congestive heart …
- 某些结果已被删除